J7607 – Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7607
- Long description
- Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- Short description
- Levalbuterol comp con
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2007
- Last change
- January 1, 2007 – No change
Frequently asked questions
What is HCPCS code J7607?
J7607 is a HCPCS Level II code for levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg.
Does Medicare cover J7607?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7529 – Mycophenolate mofetil, for suspension, oral, 5 mg
- J7530 – Mycophenolate mofetil (myhibbin), oral suspension, 5 mg
- J7531 – Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
- J7599 – Immunosuppressive drug, not otherwise classified
- J7601 – Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604 – Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 – Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 – Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7608 – Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 – Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 – Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 – Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 – Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 – Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.